1

Business Today | August 31, 2014

Business Today | August 31, 2014 of Fame... · KIRAN MAZUMDAR-SHAW CMD. Biocon Ltd In January, her company's partnership with Mylan launch a biosimilar and a targeted therapy to treat

Download PDF Report

Upload
ngodien
View
222
Download
4

Embed Size (px)

Citation preview

Page 1: Business Today | August 31, 2014 of Fame... · KIRAN MAZUMDAR-SHAW CMD. Biocon Ltd In January, her company's partnership with Mylan launch a biosimilar and a targeted therapy to treat

Business Today | August 31, 2014

Mylan and Biocon obtain firstUSr ival to Herceptin · 2018. 11. 20. · 2 GENERICSbulletin 8D ecember2017 COMPANY NEWS MANUFACTURING Reddy’scanresume producingforEurope DrR eddy’s

Mylan and Biocon obtain firstUSr ival to Herceptin · 2018. 11. 20. · 2 GENERICSbulletin 8D ecember2017 COMPANY NEWS MANUFACTURING Reddy’scanresume producingforEurope DrR eddy’s

Documents

NOT A SHARK IN A SUIT. NOT A CORPORATE WOLF. IN … · Kiran Mazumdar Shaw Sadhguru - Yogi, Mystic & Founder of Isha Foundation Kiran Mazumdar Shaw - Chairperson and MD, BIOCON Vijay

NOT A SHARK IN A SUIT. NOT A CORPORATE WOLF. IN … · Kiran Mazumdar Shaw Sadhguru - Yogi, Mystic & Founder of Isha Foundation Kiran Mazumdar Shaw - Chairperson and MD, BIOCON Vijay

Documents

Unlocking the potential for growth in dynamic organisationsgtw3.grantthornton.in/assets/Profile-Grant_Thornton_India_LLP-2013.pdf · Kiran Mazumdar Shaw CMD, Biocon Limited "Grant

Documents

Here we are with more views, concepts, history and facts ...€¦ · Another example is Kiran Mazumdar Shaw who is the Chairman and Managing Director of Biocon Limited, a biotechnology

Here we are with more views, concepts, history and facts ...€¦ · Another example is Kiran Mazumdar Shaw who is the Chairman and Managing Director of Biocon Limited, a biotechnology

Documents

Trends in the Pharmaceutical Industry and the Potential ... · He is now Chairman and Senior Partner of Hale & Tempest Co Ltd . Hale & Tempest ... Biocon, India & Mylan, USA ... Japan

Trends in the Pharmaceutical Industry and the Potential ... · He is now Chairman and Senior Partner of Hale & Tempest Co Ltd . Hale & Tempest ... Biocon, India & Mylan, USA ... Japan

Documents

エコノミスト・インテリジェンス・ユニット報告書 …...Kiran Mazumdar-Shaw CEO, Biocon John Watson President of Strategic Partnering, Chief Commercial Officer,Covance

エコノミスト・インテリジェンス・ユニット報告書 …...Kiran Mazumdar-Shaw CEO, Biocon John Watson President of Strategic Partnering, Chief Commercial Officer,Covance

Documents

Shangri-La, Bangalore | India 2017 - Conference Announcement.pdf · Kiran Mazumdar-Shaw is an Indian entrepreneur.She is the chairman and managing director of Biocon Limited, a biotechnology

Shangri-La, Bangalore | India 2017 - Conference Announcement.pdf · Kiran Mazumdar-Shaw is an Indian entrepreneur.She is the chairman and managing director of Biocon Limited, a biotechnology

Documents

UNLOCK YOUR POTENTIAL FOR EXCELLENCE IN …Kiran Mazumdar – Shaw Chief Mentor, Biocon Academy At a Glance Key Innovations India’s largest Biologics capacity in compliance with

UNLOCK YOUR POTENTIAL FOR EXCELLENCE IN …Kiran Mazumdar – Shaw Chief Mentor, Biocon Academy At a Glance Key Innovations India’s largest Biologics capacity in compliance with

Documents

CITI-NEWS LETTER · Mahindra Group, Pawan Munjal from Hero Motocorp, Ramesh Chandra from Unitech, Kiran Mazumdar Shaw from Biocon, K Satish Reddy from Dr Reddy’s, Habil Khorakiwala

CITI-NEWS LETTER · Mahindra Group, Pawan Munjal from Hero Motocorp, Ramesh Chandra from Unitech, Kiran Mazumdar Shaw from Biocon, K Satish Reddy from Dr Reddy’s, Habil Khorakiwala

Documents

January 2011 - Biocon · Biosimilars partnership - Mylan Monoclonal Antibodies (MAb) Combines Biocon's R&D and manufacturing of novel biologics/bio-generics with Mylan’s regulatory

January 2011 - Biocon · Biosimilars partnership - Mylan Monoclonal Antibodies (MAb) Combines Biocon's R&D and manufacturing of novel biologics/bio-generics with Mylan’s regulatory

Documents

BIOCON AND HCG GROUP OF HOSPITALS LTD. JOIN HANDS TO … · India as a global destination for translational research and cutting edge clinical trials.” said Kiran Mazumdar Shaw,

BIOCON AND HCG GROUP OF HOSPITALS LTD. JOIN HANDS TO … · India as a global destination for translational research and cutting edge clinical trials.” said Kiran Mazumdar Shaw,

Documents

Biosimilars: Commercial Perspective · PDF fileBiosimilars: Commercial Perspective FTC Presentation, February 4th 2014 Aaron (Ronny) Gal, Ph.D. ... Mylan/Biocon Baxter/ Momenta Merck

Biosimilars: Commercial Perspective · PDF fileBiosimilars: Commercial Perspective FTC Presentation, February 4th 2014 Aaron (Ronny) Gal, Ph.D. ... Mylan/Biocon Baxter/ Momenta Merck

Documents

Corporate Presentation June-2013 - Biocon · Annual General Meeting Kiran Mazumdar Shaw Chairperson & Managing Director June 30th, 2016 Biocon Research Centre HAIRPERSON’S SPEEH

Corporate Presentation June-2013 - Biocon · Annual General Meeting Kiran Mazumdar Shaw Chairperson & Managing Director June 30th, 2016 Biocon Research Centre HAIRPERSON’S SPEEH

Documents

IDirect Biocon Q4FY16content.icicidirect.com/mailimages/IDirect_Biocon_Q4FY16.pdfKiran Mazumdar-Shaw. Unlike most pharma companies that are chemical based, Biocon has carved out its

IDirect Biocon Q4FY16content.icicidirect.com/mailimages/IDirect_Biocon_Q4FY16.pdfKiran Mazumdar-Shaw. Unlike most pharma companies that are chemical based, Biocon has carved out its

Documents

At a Glance - IBAB · 2020. 1. 31. · Kiran Mazumdar-Shaw Chairperson and MD, Biocon Group M Vijayan INSA Albert Einstein Research Professor and formerly, Associate Director, Indian

At a Glance - IBAB · 2020. 1. 31. · Kiran Mazumdar-Shaw Chairperson and MD, Biocon Group M Vijayan INSA Albert Einstein Research Professor and formerly, Associate Director, Indian

Documents

Biocon Limited’s Q2 FY15 Earnings Conference Call October ... Call/132523_20141022.pdf · Kiran Mazumdar-Shaw: Thank you and let me welcome all of you to this Investor Analyst Call

Biocon Limited’s Q2 FY15 Earnings Conference Call October ... Call/132523_20141022.pdf · Kiran Mazumdar-Shaw: Thank you and let me welcome all of you to this Investor Analyst Call

Documents

KecK Graduate InstItute Annual Report Biocon founder Kiran Mazumdar-Shaw to establish the Biocon Academy and its certificate program taught online by KGI ... KecK graDuate inStitute

KecK Graduate InstItute Annual Report Biocon founder Kiran Mazumdar-Shaw to establish the Biocon Academy and its certificate program taught online by KGI ... KecK graDuate inStitute

Documents

LSF magazine - Science · PDF fileBEER TO BIOPHARMACEUTICALS BIOCON'S KIRAN MAZUMDAR-SHAW The biotechnology industry began in the 1970s as a mostly American phenomenon and largely

LSF magazine - Science · PDF fileBEER TO BIOPHARMACEUTICALS BIOCON'S KIRAN MAZUMDAR-SHAW The biotechnology industry began in the 1970s as a mostly American phenomenon and largely

Documents

NOT A SHARK IN A SUIT. NOT A CORPORATE WOLF. IN · PDF fileKiran Mazumdar Shaw Sadhguru - Yogi, Mystic & Founder of Isha Foundation Kiran Mazumdar Shaw - Chairperson and MD, BIOCON

NOT A SHARK IN A SUIT. NOT A CORPORATE WOLF. IN · PDF fileKiran Mazumdar Shaw Sadhguru - Yogi, Mystic & Founder of Isha Foundation Kiran Mazumdar Shaw - Chairperson and MD, BIOCON

Documents

R.D.C.A eqEcbZ dh dk;Zd kfj - Medical Darpan · 2018-12-30 · Biocon and Mylan Announce Positive CHMP Opinion for Fulphila®, Biosimilar Pegfilgrastim Bengalore:- Biocon Ltd.,Mob:-

R.D.C.A eqEcbZ dh dk;Zd kfj - Medical Darpan · 2018-12-30 · Biocon and Mylan Announce Positive CHMP Opinion for Fulphila®, Biosimilar Pegfilgrastim Bengalore:- Biocon Ltd.,Mob:-

Documents

BIOCON Q1FY2005 RESULTS CONFERENCE CALL … Call/132523_20040714.pdf · Kiran Mazumdar-Shaw: Well, we are still confident of launching it in the first half. We are only awaiting final

BIOCON Q1FY2005 RESULTS CONFERENCE CALL … Call/132523_20040714.pdf · Kiran Mazumdar-Shaw: Well, we are still confident of launching it in the first half. We are only awaiting final

Documents

Enabling Entrepreneurship for Inclusive Economic Development by Kiran Mazumdar Shaw, Biocon, March 15, 2013

Enabling Entrepreneurship for Inclusive Economic Development by Kiran Mazumdar Shaw, Biocon, March 15, 2013

Documents

Kiran Mazumdar-Shaw 1 - Biocon · Flexible service models including FTE/FFS, Co -development and Risk Sharing Strong infrastructure in early clinical development and translational

Kiran Mazumdar-Shaw 1 - Biocon · Flexible service models including FTE/FFS, Co -development and Risk Sharing Strong infrastructure in early clinical development and translational

Documents

res.hurun.netres.hurun.net/.../file/20170926/201709261003198639442.docx · Web viewPrithvi Raj Singh Oberoi East India Hotels 2008 Bhushan & Shri Kiran Mazumdar-Shaw Biocon 2005/1989

res.hurun.netres.hurun.net/.../file/20170926/201709261003198639442.docx · Web viewPrithvi Raj Singh Oberoi East India Hotels 2008 Bhushan & Shri Kiran Mazumdar-Shaw Biocon 2005/1989

Documents

OMPI - World Intellectual Property Organization...Kiran Mazumdar-Shaw, de Biocon, transforma la salud mundial 34 Igualdad de género en la agricultura africana: un imperativo para

OMPI - World Intellectual Property Organization...Kiran Mazumdar-Shaw, de Biocon, transforma la salud mundial 34 Igualdad de género en la agricultura africana: un imperativo para

Documents

Biocon Limited’s Q1 FY16 Earnings Conference Call July 24, 2015 · July 24, 2015 Key Participants from Biocon Group’s Senior Management Team Kiran Mazumdar Shaw: Chairperson and

Biocon Limited’s Q1 FY16 Earnings Conference Call July 24, 2015 · July 24, 2015 Key Participants from Biocon Group’s Senior Management Team Kiran Mazumdar Shaw: Chairperson and

Documents

CHAPTER III WOMEN ENTREPRENEURSHIP IN INDIA – …shodhganga.inflibnet.ac.in/bitstream/10603/37218/3/chapter3.pdf · like Kiran Mazumdar Shaw of Biocon. This chapter draws a brief

CHAPTER III WOMEN ENTREPRENEURSHIP IN INDIA – …shodhganga.inflibnet.ac.in/bitstream/10603/37218/3/chapter3.pdf · like Kiran Mazumdar Shaw of Biocon. This chapter draws a brief

Documents

Biocon (Biocon) | 664content.icicidirect.com/mailimages/IDirect_Biocon_Q3FY19.pdf · Biocon was established in 1978 by first generation entrepreneur Dr Kiran Mazumdar-Shaw. Unlike

Biocon (Biocon) | 664content.icicidirect.com/mailimages/IDirect_Biocon_Q3FY19.pdf · Biocon was established in 1978 by first generation entrepreneur Dr Kiran Mazumdar-Shaw. Unlike

Documents

JN406 Coming of Age of Biosimilars Whitepaper 4/media/Informa...(Biocon/Mylan, Momenta/Shire) share the global competitive arena. Interestingly, a few sponsors were limited to “Global

JN406 Coming of Age of Biosimilars Whitepaper 4/media/Informa...(Biocon/Mylan, Momenta/Shire) share the global competitive arena. Interestingly, a few sponsors were limited to “Global

Documents

BNP PariBas iNdividual PhilaNthroPy iNdex - Forbes · The BNP Paribas Individual Philanthropy Index ... Kiran Mazumdar-Shaw, Chairman, Biocon, India Shiv Nadar, Founder, HCL Group,

BNP PariBas iNdividual PhilaNthroPy iNdex - Forbes · The BNP Paribas Individual Philanthropy Index ... Kiran Mazumdar-Shaw, Chairman, Biocon, India Shiv Nadar, Founder, HCL Group,

Documents